Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE089A01031 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Dr Reddys Labo Dr Reddys Laboratories Ltd. | BSE 1236.60 7.35 (0.60%) | NSE 1236.70 7.10 (0.58%) | Trade | Add

BSE Live

Nov 13, 13:20

1236.60 7.35 (0.60%)

Volume

AVERAGE VOLUME

5-Day

46,577

10-Day

92,414

30-Day

232,023

25,275

Prev. Close

1229.25
Open Price

1241.75

Bid Price (Qty.)
1236.50 (6)
Offer Price (Qty.)
1237.15 (76)

NSE Live

Nov 13, 13:20

1236.70 7.10 (0.58%)

Volume

AVERAGE VOLUME

5-Day

1,678,193

10-Day

2,666,206

30-Day

2,191,197

734,973

Prev. Close

1229.60
Open Price

1235.80

Bid Price (Qty.)
1236.70 (97)
Offer Price (Qty.)
1236.90 (7)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Dr Reddys Laboratories (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	23,046.80	19,404.10	16,899.10	14,315.30	13,281.40
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	23,046.80	19,404.10	16,899.10	14,315.30	13,281.40
Total Operating Revenues	23,115.40	19,483.80	16,962.50	14,405.20	13,349.10
Other Income	1,003.40	862.30	591.30	482.00	801.10
Total Revenue	24,118.80	20,346.10	17,553.80	14,887.20	14,150.20
EXPENSES
Cost Of Materials Consumed	3,799.70	3,291.50	3,161.40	3,378.40	3,266.30
Purchase Of Stock-In Trade	2,439.90	1,986.60	1,779.30	2,057.10	1,252.30
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-173.90	-238.80	129.50	-389.60	-395.60
Employee Benefit Expenses	3,287.50	3,085.70	2,832.60	2,434.60	2,270.10
Finance Costs	109.90	21.80	16.90	38.00	46.70
Depreciation And Amortisation Expenses	1,039.40	975.60	923.20	814.30	835.00
Other Expenses	6,276.80	5,406.40	4,839.80	4,320.80	3,804.20
Total Expenses	16,882.90	14,554.80	13,687.80	12,663.40	11,094.00
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	7,235.90	5,791.30	3,866.00	2,223.80	3,056.20
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	7,235.90	5,791.30	3,866.00	2,223.80	3,056.20
Tax Expenses-Continued Operations
Current Tax	1,790.50	1,361.80	864.10	392.60	540.10
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	96.00	87.50	389.10	208.00	329.70
Tax For Earlier Years	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	1,886.50	1,449.30	1,253.20	600.60	869.80
Profit/Loss After Tax And Before ExtraOrdinary Items	5,349.40	4,342.00	2,612.80	1,623.20	2,186.40
Profit/Loss From Continuing Operations	5,349.40	4,342.00	2,612.80	1,623.20	2,186.40
Profit/Loss For The Period	5,349.40	4,342.00	2,612.80	1,623.20	2,186.40
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	64.22	260.95	157.37	97.85	131.84
Diluted EPS (Rs.)	64.22	260.46	157.03	97.85	131.46
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	0.00
Indigenous Raw Materials	0.00	0.00	0.00	0.00	0.00
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	666.20	664.80	497.90	414.60	414.70
Tax On Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend Rate (%)	800.00	800.00	800.00	600.00	500.00